We are investigating Foundation Medicine, Inc. (“FMI” or the “Company”) (FMI) relating to the proposed acquisition of the Company by Swiss healthcare company Roche Holding AG (“Roche”). As a result of the merger, FMI shareholders are only anticipated to receive $137.00 in cash for each FMI share they own.